Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients: a randomized, controlled trial (Q78102275)
Jump to navigation
Jump to search
scientific article published on 01 August 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients: a randomized, controlled trial |
scientific article published on 01 August 1999 |
Statements
Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients: a randomized, controlled trial (English)
Facon T
Harousseau JL
Maloisel F
Attal M
Odriozola J
Alegre A
Schroyens W
Hulin C
Schots R
Marin P
Granena A
De Waele M
Pigneux A
Méresse V
Clark P